The report provides a detailed analysis essential for establishing a probucol production plant. It encompasses all critical aspects necessary for probucol production, including the cost of probucol production, probucol plant cost, probucol production costs, and the overall probucol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a probucol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Probucol is a lipid-lowering and antioxidant drug that is used to treat hypercholesterolemia. It works by accelerating LDL cholesterol catabolism, inhibiting its oxidation, and promoting xanthoma regression. It is utilised for managing primary hyperlipoproteinaemias, both heterozygous and homozygous familial hypercholesterolemia.
It is also used for secondary hyperlipidemia from conditions like nephrotic syndrome or diabetes, and prevents restenosis or major adverse cardiovascular events post-percutaneous intervention. It shows secondary preventive benefits against cerebro- and cardiovascular events in high-risk patients, like those with heterozygous FH. Its common side effects include gastrointestinal issues like diarrhoea, nausea, flatulence, and abdominal discomfort, plus skin reactions such as rash and itching, with rare headaches or paresthesia.
The probucol market is fuelled by increasing cases of hypercholesterolemia and cardiovascular diseases. The rise in the ageing population susceptible to lipid disorders and growing recognition of its antioxidant properties as a statin alternative or complement contribute to its demand. Its expanding use in Asia-Pacific countries, along with improved healthcare access and local production, boosts its market. The industrial probucol procurement is affected by the dominance of hospital pharmacies for close monitoring and affordability via generic availability after patent expiry. The steady supply chains favouring cost-effective suppliers, rising healthcare budgets in emerging regions, and regulatory demands for safety data that guide approvals and negotiations impact its sourcing.
Raw Material for Probucol Production
According to the probucol production plant project report, the key raw materials used in the production of probucol include 2,6-di-tert-butyl-4-mercaptophenol, acetone, and sodium methylate.
Production Process of Probucol
The extensive probucol production cost report consists of the following major industrial production process:
- From 2,6-di-tert-butyl-4-mercaptophenol: The production process of probucol starts with the deprotonation of 2,6-di-tert-butyl-4-mercaptophenol. It is done using a base like sodium methylate in methanol, followed by the addition of acetone under pressure to form an alkene intermediate. To this, mercaptophenol is added along with a strong acid like HCl to adjust pH, and the mixture is heated to complete the thioaddition reaction to get crude probucol. The product is cooled, filtered, washed, and purified to get pure probucol as the final product.
Probucol has the molecular formula of C31H48O2S2 with a molecular weight of 516.84 g/mol. It is a highly lipophilic, white, odourless crystalline powder with two phenolic hydroxyl groups, two thioacetal linkages, and four bulky tert-butyl substituents. It is practically insoluble in water but freely soluble in most organic solvents like chloroform, acetone, and ethanol. It exhibits a melting point of 126–128 degrees Celsius and a high logP value around 9.9–11.3, indicating strong partitioning into lipids. It shows UV absorption maximum at 242 nm in methanol, with a topological polar surface area of 91.1 Ų. These properties drive its preferential accumulation in low-density lipoproteins, antioxidant activity via radical scavenging, and slow elimination half-life exceeding days due to extensive tissue deposition.